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Abstract
Positron emission tomography (PET) is a nuclear medicine
imaging modality based on the administration of a positron-
emitting radiotracer, the imaging of the distribution and
kinetics of the tracer, and the interpretation of the physio-
logical events and their meaning with respect to health and
disease. PET imaging was introduced in the 1970s and
numerous advances in radiotracers and detection systems
have enabled this modality to address a wide variety of
clinical tasks, such as the detection of cancer, staging of
Alzheimer’s disease, and assessment of coronary artery
disease (CAD). This review provides a description of the
logic and the logistics of the processes required for PET
imaging and a discussion of its use in guiding the treatment
of CAD. Finally, we outline prospects and limitations of
nanoparticles as agents for PET imaging.
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blood-tissue exchange model; oxygen-15; ammonia N-13; gamma
camera; SPECT
1. Introduction to positron emission
tomography (PET) and single photon emission
computed tomography (SPECT) imaging
M
odern non-invasive diagnostic imaging proce-
dures have improved patient care by making
earlier diagnoses with greater precision. X-
radiography, using an external source of a beam of X-
rays, paved the way, providing planar images of X-ray
attenuation, or tissue density. These provided increasingly
highspatial resolution asX-ray sourcesweremadesmaller
and as film grain size was reduced. The next step
transformed the field by using intravenous injections of
gamma-emitting tracers to track and image cellular and
organ functions. This modality depends on collimation to
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(page number not for citation purpose)define the direction of allowable photons that reach the
crystal detectors. While gamma camera images were
initially only planar, like the X-ray of the time, gamma
photons are emitted from radioactive decay in random
directionsin3-space.Subsequentrotatinggammacameras
have provided 3D images based upon tomographic recon-
structions from multiple views: this is single photon
emission-computed tomography (SPECT).
Positron-emitting tracers allow a next step, even
though they are short-lived and cannot be detected
directly outside the body. When positrons are emitted,
they travel about a millimeter and are then annihilated,
giving rise to the emission of two gamma photons, which
readily penetrate tissue and are detected outside by arrays
of crystals. Positron emission tomography (PET) should
probably have been called dual photon ECT (DPECT),
but PET is expressive and efficient. The key is that the
two photons are emitted in opposite directions, therefore
when detected simultaneously in a pair of crystals, one
knows that they came from somewhere on the line
between the two crystals. This greatly improves the spatial
resolution. Because gamma-emitting and positron-emit-
ting tracers can be incorporated into a wide variety of
molecules of biological interest, the developments opened
a field of biochemical exploration   molecular medicine.
In this review, we offer a brief introduction to the
physics and applications of these two imaging modalities,
with a focus on quantitative cardiac PET imaging.
Interested readers are directed to other sources for in-
depth discussions of the physics, chemistry, and applica-
tions of PET and PET/CT (1 5).
1.1. Basic physics of positron emission tomography
(PET) imaging
PET imaging requires producing a positron-emitting
radioisotope. These may be made in a cyclotron by
bombarding stable nuclei with high-energy particles. The
isotopes are then synthesizedwith biologically meaningful
materials to form a radiotracer, or radiopharmaceutical.
This process essentially ‘labels’ a substance that has a
desired physiologic behavior. Numerous radiotracers have
been developed for a wide range of applications. Table 1
presents some of the common radiopharmaceuticals.
As a positron-emitting radioisotope decays to a stable
state it emits the positron (positive beta particle) that
travels only a short distance before being annihilated on
contact with an electron (negative beta particle) as in
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Table 1. Common radiopharmaceuticals for PET
Application PET probe Mechanism
Glucose metabolism [F-18] fluorodeoxyglucose (FDG)
a Accumulates as sugar phosphate
Bone scanning [F-18] fluoride* Incorporation into bone
Blood flow [N-13] ammonia* Accumulates as glutamate
[Rb-82] rubidium* Cell accumulation like potassium
[0-15] H2O Inert highly diffusible indicator
[F-18] BMS-747158-02 Inhibitor of mitochondrial complex I
[Cu-62] PTSM Diffusible indicator with multiple retention mechanisms
(mitochondrial reduction, enzymatic, etc.)
Hypoxia [F-18] fluoromisonidazole (FMISO) Redox indicator shows hypoxia
Proliferation [F-18] fluorothymidine (FLT) Incorporation into DNA
Fatty acid oxidation [C-11] acetate Uptake and clearance by FA oxidation
Protein metabolism [C-11] choline Incorporation into phospholipids
aPET radiopharmaceuticals with FDA approval for certain clinical applications (17, 18).
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the particular emission energy of the isotope and on the
density of the tissue. The annihilation produces two 511
keV photons that travel at light speed in opposite
directions very close to 180 degrees from each other.
The PET scanner detects these photons by their near
simultaneous detection with the crystal array, providing
the location of the annihilation. Thus, PET scanners do
not image the origin of the positron decay, but rather the
location of the positron-electron annihilation.
Fig. 2 illustrates the overall process. The positron-
labeled tracers are usually injected intravenously into the
patient and distribute throughout the body, exchanging
between blood and tissue, and then binding or participat-
ing in metabolic reactions, that is, becoming localized in
accord with the physiological circumstances, and decay
exponentially with time. The 511-keV photons leave the
annihilation site, travel through the body, and, in the
ideal case, are detected by the scanner. The scanner
contains a ring of scintillation detectors, which surround
the patient. When one photon enters a detector, it
produces a small amount of light, which is amplified
into an electrical signal and is detected as a single count.
After receiving one single count, the system waits some
nanoseconds for another single count to occur in another
detector. If two single counts occur in this prescribed time
interval, these photons are paired together and the system
stores it as a coincident event. This coincident event
signifies that an annihilation occurred somewhere along
the line connecting the two single detections. The line
connecting two detectors is referred to as a line-of-
response. (When time-of-flight detection is used, the
difference in arrival times defines the position of
the annihilation event within about 10 cm.) After the
collection of numerous photons, a single line-of-response
effectively measures the integral of annihilations along a
single line through the patient. These lines in a single
transaxial plane are organized by their azimuthal angle
and radial distance (as illustrated in Fig. 2) and stored in
a 2D matrix called a sinogram (a single annihilation site
will map a sine wave in the sinogram domain). The
sinogram is the Radon transform of the annihilation
distribution in the object and is conceptually the same
data space used in all tomographic modalities (6).
Tomographic reconstruction methods are employed to
reconstruct images from sinogram data. In general,
images are formed for each slice and then stacked
together to form 3D image volumes. There are numerous
methods for tomographic reconstruction and all seek to
perform some variant of the inverse Radon transform of
the raw sinogram data. The leading approaches for
clinical PET include filtered back-projection (FBP) (6)
and ordered subsets expectation maximization (OSEM)
(7) The FBP method is analytic, offering a fairly simple
formula for the inverse Radon transform. This method
offers a fast solution at the expense of less desirable noise
Fig. 2. Transaxial view of ring of detectors and patient demonstrating the types of coincident events. (A) True coincidence. (B)
Random (accidental) coincidence. (C) Scattered coincidence. The annihilations marked with solid black dots do not occur along
the detected line-of-response in the second two cases leading to increased systemic noise in the data.
Fig. 1. Basic principle of PET imaging: decay of radio-
nuclide, positron emission, multiple scatters, annihilation
with electron, and production of two collinear 511-keV
photons. (Not to scale.)
Quantitative imaging of coronary blood flow
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reconstruction in X-ray computed tomography (CT).
The OSEM method is an iterative method that seeks to
find the maximum likelihood solution for the image
based on a Poisson statistical model of the data. The
OSEM method is more computationally intensive, but
offers potentially better signal to noise properties.
1.2. Factors degrading image quality in positron
emission tomography (PET)
As with all modalities, PET has physical limitations that
limit its signal to noise performance. The previous
description focused on the ideal case. In reality, as the
511-keV photons travel through tissue, many of them
interact through Compton scattering (and with small
probability through photoelectric effect) and change their
direction. These interactions cause deviation from a
straight path, resulting in ‘attenuated’ photons. The
probability that a photon will travel along a straight
line is given by
P(x?) exp

 g
x?
0
m(x)dx

;
here x is the location along the line from 0 to x? through
the patient with different linear attenuation coefficients,
m(x). The attenuation coefficients vary based on the type
of tissues in the imaged volume and the energy of the
incident photons. X-ray imaging measures variation in
attenuation. PET imaging attempts to measure the
location of the radiotracer and attenuation confounds
this information. In whole-body PET imaging, as much
as 90% of the coincident events are lost due to attenua-
tion. PET systems have dedicated components to obtain
an attenuation map of the imaged volume in each
individual patient. Standalone PET scanners have a
transmission, rotating, radioactive rod source that essen-
tially performs a low-resolution CT scan using the PET
detectors. PET/CT scanners use the CT component to
form the attenuation map (8). The attenuation map of the
patient is forward projected into the same data space as
the PET data and applied as an attenuation correction.
If one or both of the annihilation photons scatter
before detection, then the scanner could incorrectly
position the event. Fig. 2C illustrates the mispositioning
error of these scattered coincident events. Scattered events
can account for as much as 40% of the detected events in a
whole-body acquisition and result in an increased back-
ground noise in the PET image. Reduction and correction
algorithms for scattered events can reduce the bias caused
by position-dependent scatter, but cannot fully remove
this major contributor to background noise (9, 10).
Another source of noise in PET are random events
caused by the incorrect pairing of photons from different
annihilations. As shown in Fig. 2B, random events arise
from a variety of situations, such as the highly likely
attenuation of one photon or when the system fails to
detect a photon. As with scatter correction, randoms
correction algorithms can alleviate some but not all of the
noise contribution of this physical limitation (11).
The noise in PET depends on the number of events
detected. This count-limited modality benefits from the
long acquisition times needed to acquire as many true
events as possible. Increased injected activity will not only
result in a beneficial linear increase in true events, but
also in a detrimental linear increase in scatter events and
a highly detrimental square increase in random events.
PET systems and acquisition protocols are designed to
optimize the tradeoffs of true, scatter, and random events
(12). But it is obvious that rapid transients in local tissue
concentrations will involve a tradeoff between the accu-
racy of each image acquired and the number of events
recorded. Later, we discuss this tradeoff, noting that
transients are best handled using very short time-win-
dows in order to avoid distortion of the true time course,
even though the time-activity curves (TAC) appear
relatively noisy.
In terms of signal strength, the resolution of PET will
always be limited by the nature of positron annihilation
(13). As positrons travel through tissue, they experience
multiple interactions (mostly Coulomb) until their kinetic
energy reduces to thermal energies and they annihilate
with an electron. Higher energy positrons travel farther
from the site of decay than lower energy positrons. One
way to characterize this positron range for an isotope is
the radius that includes 75% of all annihilation events.
For common PET isotopes, this radius is between 1.2 mm
for F-18 and 12.4 mm for Rb-82. Furthermore, the
photons leaving the site of annihilation are slightly non-
collinear (within 0.238) (14). In current whole-body
PET tomographs with a ring diameter of 70 cm, non-
collinearity results in an effective resolution loss of
approximately 1.5 mm.
Along with these inherent physical limitations, the
detection system introduces resolution limitations (15).
The detectors contain scintillation crystals that stop the
511-keV photon and convert its energy into detectable
light. The emitted light then travels through the crystal
and into photomultiplier (PMT) tubes for amplification
and coincidence detection, thereby defining the line
between the detectors giving positioning. Detectors have
an intrinsic spatial resolution that depends upon several
factors, including density of crystal, thickness, light guide
type, and PMT performance. When individual detectors
are combined in a full system, inter-crystal penetration,
when a photon enters one crystal and continues
to a neighboring crystal, is a common problem. In
conventional whole-body systems with a cylindrical ring
of detectors, photons traveling along paths at the edge of
the transaxial field of view can be incorrectly assigned
Adam M. Alessio et al.
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the field of view mispositioning is commonly called
parallax error.
1.3. Positron emission tomography/computed
tomography (PET/CT)
The first PET/CT scanner was introduced in 1998,
providing a single device with both ‘functional’ (PET)
and ‘anatomic’ (X-ray CT) imaging capabilities (16).
These systems consist of essentially separate PETand CT
subsystems and a shared patient bed to provide a shared
coordinate system. This design allows for simple ‘hard-
ware’ alignment of the PET image of radiotracer
distribution and the CT image of tissue attenuation,
providing high-resolution anatomic detail. Together with
the primary benefit of aligned functional and anatomic
images, the CT scanner also provides a fast, relatively
noise-free attenuation map for PET attenuation correc-
tion. These combined systems have developed into the
industry standard for PET imaging, and the majority of
current commercial, clinical PET systems are now PET/
CT systems.
1.4. Common applications of positron emission
tomography (PET)
The majority of PET scans are performed for cancer
imaging with
18F-fluorodeoxyglucose (FDG). FDG is
transported into cells, phosphorylated via a hexokinase,
like glucose, and is trapped in the cells as FDG 6-
phosphate. Hydrolysis via glucose-6-phosphatase is sub-
stantial in the liver and kidney, but the heart and brain
have little of the enzyme. In the macroscopic view, FDG
is distributed in the body based on local rates of glu-
cose consumption. Considering that many tumors are
hypermetabolic and preferentially use glucose, increased
FDG can highlight the presence of rapidlygrowing tumor
cells. Fig. 3 presents an example of a whole-body FDG
image showing the normal distribution of FDG in tissues
throughout the body, including increased uptake in the
bladder. The abnormal focal uptake in the abdomen
highlights hypermetabolic cancerous cells in the left lobe
of the liver and upper abdominal lymph nodes.
PET can also be used to image several tracers for
myocardial perfusion. For example,
13N-ammonia (NH3)
is metabolically trapped in tissues and preferentially
accumulates in regions with increased blood flow.
This mechanism will be discussed in detail later.
Fig. 4 presents an example from a cardiac ammonia
examination. Note that the isotope distribution is differ-
ent from the FDG distribution, as the mechanism and
meaning of the trapping is quite different. Table 1
presents a small sample of PET radiopharmaceuticals.
1.5. Single photon emission computed tomography
(SPECT) imaging
Single photon imaging began when Marie Curie obtained
an image of a radium-containing rockon film, but had its
real evolution in the 1950s with the manufacture of the
Anger camera, containing large planar sodium iodide
crystals backed by arrays of photodiode detectors.
Patient images were obtained by positioning the camera
over the patient. Insertion of a collimator between the
emission source and the detector scintillation crystal
improved the image so that it represented a projection
of the radiation source concentrations in the tissue. Thus,
the image represented the concentrations through the
depth of the tissue along the lines of the collimation, but
with some degradation due to scatter within the tissue,
absorption within the collimator itself, and the finite
spatial resolution of the scintillator crystal and the PMT
array.
Fig. 3. Example images from a whole-body FDG PET
examination. Transaxial image of the heart slice on the left
is one of many slices stacked together to form an image
volume, which is multiplanar reformatted into the single
coronal view (neck to thighs) on the right.
Fig. 4. Example images from a cardiac N-13 ammonia PET
examination. The left image is a transaxial image of the heart
slice showing increased ammonia uptake in the myocardium.
The right image is the coronal view (shoulder to base of
liver) showing uptake in the myocardium and liver.
Quantitative imaging of coronary blood flow
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collimator gamma camera is obtained by putting each
slice of tissue directly on the collimator face, then
reconstructing the 3D object from the multiple slices.
We used this technique to assess regional myocardial flow
distributions of macroaggregated albumin during regio-
nal ischemia (19). Later, 15 m microspheres improved the
resolution in such studies (20a). Only much later was the
microsphere method demonstrated to have almost as
good resolution for defining regional flows as the use of
completely deposited molecular markers (20b).
The gamma (Anger) camera evolved into a SPECT
system by rotating the camera around the patient,
stopping every few degrees to get a projection, and then
reconstructing using FBP. The acquisition speed was
increased by using two and then three camera heads
(collimated detector and PMT array). The SPECT
collimator stops photons traveling along oblique lines,
allowing for the detection of photons along known lines
of response. In PET, there is no need for hardware
collimation since lines of response are formed from the
pairing of two co-linear photons. Thus, PET is generally
more sensitive than SPECT, has less noise, and higher
resolution.
In addition to static planar imaging and SPECT
imaging, the same equipment can be used for planar
dynamic imaging, where a sequence of images is acquired
over time. A common application is to measure renal
clearance, i.e. glomerular filtration rate. Sequential, timed
images demonstrate where the indicator is in the renal
cortex, then in the medulla and renal pelvis, and finally in
the bladder. Another common use of single photon
protocols is gated imaging of the heart, using ECG
signals to time several distinct periods over which the
data are acquired during the cycle of systolic contraction
and diastolic relaxation. These multiple-gated acquisition
(MUGA) scans provide an accurate, non-invasive means
to measure left ventricular (LV) ejection fraction. New
dedicated cardiac SPECT cameras are being developed to
form a volumetric image without the need to rotate the
camera heads, and will be useful in imaging cardiac tracer
kinetics.
2. Positron emission tomography (PET) and
coronary artery disease (CVD)
Numerous diagnostic modalities are available to assess
the presence, severity, location, and origin of coronary
artery disease (CAD), with coronary angiography (with
X-ray) currently established as the leading method to
define the arterial anatomic state. PET imaging has been
employed to evaluate numerous cardiac pathologies,
including myocardial glucose uptake and viability with
18F-FDG, muscarinic receptor location with
11C-MQNB,
sympathetic function with
11C-meta-hydroxyephedrine,
and b-adrenergic receptor density with
11C-CGP 12177.
We focus this discussion on the most common application
of PET in cardiac imaging: assessment of myocardial
blood flow (MBF) using
13N-NH3,
82Rb, or
15O-water.
In clinical practice, regional MBFs assessed with
SPECT and PET identify regions of reduced flow as
‘cold spots,’ where there is low deposition of tracer.
Usually two doses are given a half-hour or more apart to
estimate regional perfusion under rest and stressed
conditions. Stress testing involves injecting a vasodilator
stress agent, such as dipyridamole or adenosine, to assess
whether or not coronary stenoses prevent the normal
increases in coronary flow. A comparison of stress and
rest flows provides valuable information regarding the
ability of the coronary arteries to reach maximal flow. In
addition, the extent and severity of any abnormality
provides important intermediate term (3 months to 3
years) prognostic information as to the probability of
death or myocardial infarction (21 23).
The most common clinical nuclear stress tests are
performed with SPECT scanners. SPECT imaging is the
leading perfusion imaging method because of the avail-
ability of radiotracers and scanners that are less expensive
than for PET. SPECT imaging provides a qualitative
regional perfusion map in which disease is assessed based
on the relative apparent uptake among different regions
of the heart. SPECT has a high sensitivity, 90 94% for
multivessel coronary disease. It is less sensitive, 60 76%,
for single-vessel disease (24, 25). Given that SPECT
depends on qualitative, relative differences in uptake, it is
not good for assessing balanced ischemia in which diffuse
disease is present in all three coronary vessels. This is part
of the reason for its rather poor sensitivity (26).
A nuclear stress test with PEToffers several advantages
over SPECT. Numerous detailed clinical comparisons of
cardiac SPECTand PET have been performed (27 29). In
general, SPECT imaging is inferior to PET owing to
poorer spatial resolution, because resolution is dependent
on the distance from the detectors, and the inherent
difficulty of performing attenuation correction in SPECT.
PET has been shown to have improved specificity in
obese patients (84% PET versus 69% SPECT) (30). In
practice, PETexaminations reduce diagnostic uncertainty
compared to SPECT (29, 31). An additional major
benefit of PET over SPECT is that it has a higher
temporal resolution allowing for the acquisition of a
dynamic series to image the kinetics of the radiotracer
through the heart. This dynamic imaging capability
permits the absolute quantification of blood flow as
discussed later. Quantification of absolute flow is parti-
cularly important in patients with balanced disease in all
coronary vessels or microvascular disease (e.g. diabetes,
hypertension), where there are no regions that can serve
as a ‘normal’ reference.
To provide a sense of the basic steps of a cardiac PET
imaging protocol, Fig. 5 illustrates the components of a
Adam M. Alessio et al.
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13N-NH3 PET/CT imaging examination. PET/CT
imaging sessions begin with a CTscout scan to determine
the scan range of subsequent acquisitions. Then, addi-
tional CT acquisitions can be performed, such as
a calcium score CT, to provide additional diagnostic
side-information. The
13N-NH3 is prepared by cyclotron
bombardment and purification. After intravenous injec-
tion, a series of PET images are acquired over multiple
time frames. From the image intensities in chosen regions
of interest (ROI), we obtain time activity curves (TAC)
of tracer concentration over 2 3 min. The TAC are the
‘raw’ information used to estimate absolute MBF within
that ROI. Then, a PET acquisition with cardiac gating is
performed to generate qualitative maps of blood flow
across a cardiac cycle along with assessment of global
and regional ventricular function. Finally, a CT is
performed for attenuation correction of the PET images.
This procedure is used to obtain data on the patient at
rest and again after pharmacologic stress to determine
the responsiveness of the coronary arteries to an in-
creased demand for oxygen delivery.
2.1. Why quantify myocardial blood flow (MBF)?
Won’t the qualitative image suffice for diagnosis?
Nuclear stress scans conventionally rely on qualitative
measurements of regional perfusion determined through
relative regional differences in uptake. Qualitative images
have certainly proven useful in the detection of coronary
artery disease, prognosis, and clinical management of
patients. The quantification of the regional blood flow
adds value to the qualitative information as summarized
in Table 2.
2.2. Background on quantitative myocardial blood
flow (MBF) estimation with positron emission
tomography (PET)
Estimation of MBF is done through modeling analysis of
the regional TAC of tissue tracer content following
injection upstream. The input function is obtained from
the tracer concentration-time curve upstream to the
coronary inflow, namely from the with left ventricular
(LV) or left atrial (LA) TAC data. Numerous tracers have
been used for rMBF estimation with PET:
15O-water
(diffusible) (33),
13N-NH3 (diffusible/metabolized/ re-
tained) (34, 35),
11C-acetate (extracted/metabolized)
(36), and
82Rb (extracted/retained) (37). Along with these
accepted tracers, new
62Cu and
18F labeled agents are
being explored for potentially less expensive, higher
quality MBF estimates (38, 39). A thorough comparison
of PET flow agents is presented by deKemp et al. (40).
The gold standard for flow measurements is
15O-water
because it is flow-limited in its exchange between plasma
and tissue (52). Unfortunately, this agent must be
produced in a cyclotron and has a short half-life (2.03
min), limiting its widespread use and the amount of
activity that can be delivered to the patient.
13N-NH3 has
a longer half-life (9.97 min) and is almost freely
exchangeable between plasma and cell cytoplasm at
even high levels of flow, allowing its use as a reference
standard for flow measurements. Because ammonia is
converted to
13N-glutamine and
13N-glutamate and is
retained for a long time in the myocardium, high-quality
images can be obtained from the accumulation of counts
a few minutes after injection.
82Rb has a short half-life
(1.27 min), but this isotope offers the clinical convenience
of production from a parent generator (strontium-82,
with half-life 25 days). The generator is a less expensive
source than a cyclotron and can be positioned close to the
patient, facilitating higher dose injections. Although the
extraction fraction for
82Rb is only 70 80% and lower in
high flow regions, it is still high enough for both image
interpretation and for the approximate estimation of flow.
Capillary-tissue exchange models accounting for intra-
capillary concentration gradients and permeation of the
capillary and cell membrane have been in use for years for
both multiple indicator dilution studies and for PET
studies (41 43). Somewhat different blood flow models
have beenused for the several PET tracers. In blood-tissue
exchange processes as the solute leaves the blood to cross
Table 2. Applications of myocardial blood ﬂow (MBF)
quantiﬁcation
1. Verify success of pharmacologic stress
2. Detection of global and regional disease
3. Evaluation of extent of multivessel disease
4. Evaluation of balanced coronary stenoses
5. Evaluation of microvascular disease
6. Evaluation of endothelial function
7. Monitor therapy
8. Tool to understand coronary physiology
Note: Adapted from Reference (32).
Fig. 5. Example cardiac N-13 ammonia PET/CT acquisition protocol for regional myocardial blood ﬂow, rMBF.
CTAC = cardiac time activity curves.
Quantitative imaging of coronary blood flow
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enter the parenchymal cells of an organ or tissue, the
tracer concentrations diminish along the length of the
capillary, diminishing the effluxes, which are simulta-
neously being reduced by back-diffusion from the inter-
stitial fluid into the blood as in Fig. 6. Incomplete but
simple ‘one-compartmental models,’ which assume that
theblood content of the region of interest is negligible and
that the tissue components all have the same concentra-
tion from capillary entrance to the exit, so-called ‘lumped
models,’ have often been used for estimating flow. They
use an input signal of a form either assumed or taken from
and upstream TAC signal, e.g. left atrium, and have
applied the one-compartmental model to the analysis for
15O-water (33),
13N-NH3 (44),
11C-acetate (36), and
82Rb
(37). In thesemodels, MBF is assumed proportional tothe
uptake rate constant K1. The compartmental approxima-
tion was a simplification of the principles demonstrated
by Crone (45) and Renkin (46), who showed that the
capillary membrane permeability-surface area product,
PS ml/(g min), for an axially extended capillary-tissue
exchange region could be calculated simply when there
was no return flux from tissue to the effluent blood:
PS  F loge(1   Emax);
where F is flow (ml/(g min)) and Emax is the maximal
extraction of tracer during the observation period. The
extraction is conceptually similar to the extraction E given
by arterio-venous difference divided by the inflow con-
centration in the steady state, and in the absence of return
flux from tissue to blood, it is identical to it. But usually it
is not the same, as the Emax for the tracer experiments of
Crone and of Renkin and others represents a unidirec-
tional flux, whereas the steady state E represents the
net flux. For example, the instantaneous extraction for
15O-water is virtually 100%, but its steady state net flux is
zero; likewise for the monovalent cations, Rb or K, the
tracer maximum is 70 80% (and is very flow dependent),
while, since neither is metabolized, the steady state net
flux is zero. Experimentally, the maximum instantaneous
extraction is defined relative to a simultaneously injected
reference intravascular marker. When PS/F is very high,
the extraction is close to 1, as the exponential term in the
rearranged equation goes toward zero:
Emax 1   e
 PS=F:
When PS/F (or in this case K1/F) is greater than 4,
then E is close to 1, as shown for water and for NH3 in
Fig. 7 (left panel), where the flux K1 is the extraction times
flow for each agent, plotted versus MBF. Fig. 7 (right
panel) shows the curve of clearance of the tracer into the
tissue for conditions when there is no return flux from
tissue to blood, that is, when everything that crosses the
capillary membrane into the tissue is retained. Each
extraction curve plateaus at extraction times F PS.
These equations were derived for the analysis of experi-
ments on the heart, brain, and skeletal muscle in which
points were obtained at 1 sec time intervals and were
relatively noise free. But because there is normally some
reflux by passive diffusion back into the blood, further
advances were required in the modeling to account for
concentration gradients along the length of the capillary.
Concentrations may diminish by factors of 10 100 along
the capillary, which contradicts the idea of the uniform
concentration assumed in using a compartmental stirred
tank model.
Two compartment models have also been proposed for
13N-NH3 (34) and
82Rb (47). These models include a
simple retention model assuming that some of the tracer
is retained without subsequent washout. Sensitivity
analysis suggests that these models may result in highly
variable parameter estimates unless certain values are
constrained (37, 48). Likewise, a direct comparison of one
and two compartment models for
13N-NH3 highlighted
the understanding that there is a real difference between
the two approaches (49).
The reason the one-compartment models can give
reasonable estimates of flow in spite of their simplicity
is that they provide an estimate of the mean transit time,
tmean. The PET and SPECT measures of regional flows
are not absolute milliliters per second of coronary blood
flow, but of ‘perfusion flow’ in milliliters per gram of
tissue per second, which is more to the point, allowing us
to understand metabolic rates of substrates and oxygen in
terms of moles per gram of tissue per second. The flow
per gram of tissue is F ml/(g.sec), when flow (ml/sec)
Fig. 6. Capillary-tissue exchange model simpliﬁed to two
spatially distributed regions, the capillary blood and the
extravascular tissue, composed of endothelial cells, the
parenchymal cells of the tissue and the interstitial ﬂuid
space, here assumed to have similar concentrations through-
out, as if the tracer were ﬂow-limited in its exchange rates
and not barrier- or membrane-permeation limited. One-
compartment models ignore the blood content of the ROI
and assume that upstream and downstream gradients are
eliminated by rapid axial mixing in the tissue.
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in grams, which is [r(g/ml) volume of tissue (ml)]. Thus,
F ml/(g.sec)/Vtiss (ml/g) 1/tmean, showing that tmean gives
the desired meaningful physiological information. What
is lost by using the compartmental models is the ability to
fit the data functions precisely; also lost is the interpret-
ability of other parameters, most notably the PS, the
permeability surface area of the membranes and the
volumes of distribution of the solutes. In more detailed
models, these parameters can be estimated not only from
high-resolution data such as from multiple indicator
dilution curves, where one uses two or three tracers
simultaneously, distinguishing the capillary space from
the interstitial space and cell space, but also from PET
data.
Along with the tracer kinetics, the blood flow models
must include a correction for partial volume effects and
blood pool spillover. The partial volume error is because
the PET system has a limited spatial resolution, resulting
in underestimation of uptake in small structures. In
cardiac imaging, the variations in wall thickness (parti-
cularly in the setting of myocardial scar) and wall motion
lead to bias in the regional estimates of the tracer. The
blood pool spillover occurs because the time course data
of the tracer is acquired and averaged over multiple
cardiac cycles. The tracer in the left and right ventricular
cavities, cblood, often confounds the apparent tracer level
in one portion of the myocardium. In the simplest
models, these two degradations in the TAC are corrected
with a single scalar, S, for spillover fraction, which can be
estimated by optimizing the fitting of the model to the
TAC for the ROI. Therefore, the TAC provided by
the image sequence in the ROI, cregion, is the sum of the
spillover fraction plus the activity of the region, cmyo (t):
cregion(t) S cblood(t) cmyo(t);
where S is the spillover correction factor (including
partial volume) ranging from 0 to 1. In the modeling
analysis, the solution of the equations represents cmyo (t);
the parameters to be adjusted are those of the model plus
the magnitude of S.
2.3. Axially distributed models for quantification of
myocardial blood flow
Because tracers of interest such as
13NH3,
82Rb, and
15O-water must be transported across endothelial and
myocardial cell membranes, and their retention is influ-
enced by the cellular metabolic state (governing rates of
retention and pool size), it is critical to account for the
graded diminution in concentration along each capillary-
tissue unit. This is done by using axially distributed
models, accounting for uptake at each point along the
capillary. (Stirred tank models collapse the gradients by
assuming uniformity of concentration within a capillary
200 times as long as its diameter, thereby introducing
systematic error into flow estimates.) The parameters of
models are unchanged by the choice of using partial
differential equations (PDEs) versus ordinary differential
equations (ODEs), so the difference is in the numerical
representation of the ideas. Accounting for the axial
gradients using PDEs prevents the error implicit in the
ODE representation that the tissue is a stirred tank and
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chance of exiting into the outflowing vein as material that
arrived earlier; by contrast, the PDE keeps the sequence
of the inflowing concentrations, and doesn’t slur the
shape of the input.
An experimental study on an isolated blood-perfused
rabbit heart from Deussen and Bassingthwaighte (50)
illustrates the high temporal resolution that can be
obtained with positron-emitting
15O-oxygen. The setup
is illustrated in Fig. 8: a bolus of blood labeled with
15O-oxygen is injected into the inflow to the coronary
system; the input and output TAC are recorded using
scintillator detectors surrounding the inflow and outflow
tubing; the residue function, the tracer content in the
heart itself, is recorded by coincidence detectors on either
side of the heart. The system is modeled using the PDEs
for oxygen transport through the capillaries, its non-
linear binding to oxygen, its transport across the mem-
branes into the cells where it binds to myoglobin, and its
metabolic transformation to
15O-water; the
15O-water
exchange and washout is modeled with a similar set of
PDEs, though not having to account for the binding. The
results of using the observed input function and fitting
the model simultaneously to the cardiac residue function
data and to the observed output function are shown in
Fig. 9. The axially distributed model gives quite precise
fits to the data and gives good estimates of the oxygen
consumption rate for comparison with measures ob-
tained from arterio-venous differences and the measured
blood flow.
In this situation, the transport of oxygen is mainly
within the blood because of the high affinity binding to
hemoglobin; therefore, oxygen has a short transit time
through the heart, only a little more than that of
indocyanine green (ICG), which is bound to albumin
and remains strictly intravascular. The time between the
peaks of the inflow and outflow curves for the ICG was
about 14 sec (upper panel, Fig. 9), while the time between
15O-oxygen peaks was about 18 sec (middle panel, Fig. 9).
In striking contrast, the peak of the outflowing
15O-water
curve was not reached at 60 sec (middle panel).
The blood flow was 0.8 ml/(g min). The expected
mean transit time for
15O-water is the tissue water space
(0.7890.01 ml/g) divided by the flow of intravascular
water. The flow of water is the blood flow times water
fraction of blood (Hct wRBC (1   Hct) wpl), where
Hct is hematocrit and wx is the water fraction of red blood
cells (RBC) or plasma (pl). For this experiment, the water
fraction is 0.88, givinga flowofintravascular waterof 0.70
ml/(g min) and a mean transit time of 0.78 (ml/g)/0.70 ml/
(g min) or 1.1 min. Since the modeling uses these known
fractions of blood and tissue as a part of the data set
for the model fitting, the results are completely self-
consistent.
2.4. Automation of quantitative regional flows for
functional imaging
Several efforts have centered on automating the creation
of functional images of regional flow distributions. These
methods model blood flow to each of many ROIs in the
myocardium. This process requires automating the posi-
tioning of the ROIs, the capturing of the TAC of the
tracer within each defined region, the analysis by model
fitting to the TAC to estimate the local flow, and the
displaying of the acquired composite images and of the
model estimates of the regional flows in the 3D heart.
The bull’s-eye polar map display invented by Caldwell
(51) is color or intensity coded for the magnitude of the
flow in each ROI and remains the most common method
of display. The center of the bull’s-eye is the apex of the
LV and concentric rings around it represent the circum-
ferential rings of tissue from apex toward the base of the
heart. The mapping can also be done onto a 3D cardiac
shape. These, with other patient-specific information,
provide the basis for therapy decisions.
3. Future prospects: nanoparticles and positron
emission tomography (PET)
While the majority of PET probes are formed with small
molecules or macromolecules, there has been increasing
interest in developing molecular imaging strategies using
organic and inorganic nanoparticles (53). In comparison
to other molecular imaging modalities, such as optical or
targeted contrast-enhanced MRI, PET offers potentially
superior sensitivity to smaller concentrations of molecu-
lar probes and the ability to quantify concentrations in
absolute units. Nanoparticles have interior and exterior
surfaces to which researchers have attached radionuclides
for PET imaging (54) or specific ligands for targeting
the delivery of the particles (55 57). It is this potential
for delivering drugs to targeted locations or sites with
Fig. 8. Experimental setup for isolated blood-perfused
rabbit hearts.
15O-oxygen is injected into the inﬂow. Plastic
scintillation detectors, b
 , and infrared indocyanine green
detectors, ICG, measure input and output functions for the
positron-emitting tracer and the plasma indicator. The heart
is positioned in the center of the coincidence detection
system (NaI (Tl-activated) crystals). (From Reference (50)
with permission from the American Physiological Society.)
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that can lead to combining the treatment and the
monitoring of the localization of the agent. (For a
thorough review of PET nanoparticles, readers are
referred to the review by Welch et al. (58).)
An example of PET imaging of cardiovascular disease
is a macrophage-tracking nanoparticle (59). This particle
is formed from the monocrystalline iron oxide nanopar-
ticle (MION) to which a near-infrared fluorochrome and
positron-emitting Cu-64 are attached, allowing trimod-
ality reporting with MRI, fluorescence, and PET. The
dextran-coated nanoparticles undergo non-specific pha-
gocytosis and accumulation in macrophages. Since
macrophages are a common prominent constituent of
atherosclerotic lesions (60), we speculate that nanoparti-
cles might be useful in imaging or even in treating
atherosclerotic lesions.
While there is much promise for nanoparticles in
imaging and in the targeting of chemotherapeutic agents,
toxicity may be a problem. Adding to the normal
concerns with drugs and contrast agents, one needs to
be aware that nanoparticles larger than 5 nm can collect
in the liver and spleen to reach toxic levels (61). Such
concerns have motivated efforts to replace chemically
stable particles with biodegradable ones.
4. Summary
PET provides volumetric images of radiotracer distribu-
tion. This modality is primarily employed for the detec-
tion of cancer and has proven valuable for numerous
other clinical applications including the assessment of
CAD. For CAD, both PET and SPECT can generate
qualitative maps of MBF, but PET can generate
quantitative maps of regional myocardial flows giving
direct evidence on the effect of local coronary disease of
atherosclerosis. Direct information on the atheromata is a
further possibility. The high sensitivity and quantitative
capabilities of PET imaging make it a promising modality
for molecular imaging with nanoparticle-based probes.
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